Johnson & Johnson Earnings Release Overview
Johnson & Johnson (NYSE: JNJ) is set to release its earnings results for the third quarter. This announcement is anticipated before the market opens, capturing the attention of investors and analysts alike.
Expectations Ahead of the Earnings Call
Forecasts indicate that Johnson & Johnson is expected to report earnings of $2.21 per share for the quarter. This is a decrease from the $2.66 reported in the same quarter last year. Analysts also predict that the company's revenue will reach $22.16 billion, a slight increase from last year’s $21.03 billion. Such financial updates are pivotal as they reflect the company's performance and market positioning.
Recent Acquisition Impacts
On October 9, Johnson & Johnson announced the completion of its acquisition of V-Wave, indicating strategic moves to enhance its business operations. This acquisition is expected to fortify their portfolio and potentially drive revenue growth.
Market Reaction to Previous Sessions
In the lead-up to these results, Johnson & Johnson's stock showed a modest increase, gaining 0.6% to close at $161.46. Such movements in stock price prior to earnings calls can often reflect investor sentiment and market speculation.
Insight from Analysts
Analysts frequently reassess their ratings and price targets based on emerging data and market conditions. Recently, the most accurate analysts have shared their insights regarding Johnson & Johnson's stock performance:
- Cantor Fitzgerald’s analyst Louise Chen has reaffirmed an Overweight rating with a price target set at $215, showcasing a solid accuracy rate of 67%.
- TD Cowen’s Joshua Jennings maintained a Buy rating but lowered the target price from $195 to $185, reflecting an accuracy rate of 61%.
- Meanwhile, Terence Flynn from Morgan Stanley kept an Equal-Weight rating, raising the price target slightly from $167 to $169, with an impressive accuracy of 70%.
- B of A Securities analyst Geoff Meacham adjusted his Neutral rating, reducing the target price from $180 to $170, supported by a 61% accuracy rating.
- Lastly, BMO Capital analyst James Fotheringham retained a Market Perform rating, increasing the target from $57 to $59, achieving a notable accuracy rate of 75%.
Considering JNJ Stock?
If you're contemplating an investment in Johnson & Johnson, these expert opinions can aid you in making informed decisions. Keep a close watch on how these predictions align with the company's actual performance following the earnings announcement.
Frequently Asked Questions
When will Johnson & Johnson announce its earnings results?
The company is expected to release its earnings results before the market opens.
What are the earnings expectations for Johnson & Johnson?
Analysts anticipate earnings of $2.21 per share, which is a decrease from last year.
What recent acquisition has Johnson & Johnson completed?
Johnson & Johnson recently completed its acquisition of V-Wave.
How have analysts rated Johnson & Johnson recently?
Analysts have provided various ratings ranging from Overweight to Neutral, with adjusted price targets reflecting current market assessments.
What was the recent stock price movement for JNJ?
Johnson & Johnson shares increased by 0.6%, closing at $161.46 ahead of the earnings announcement.
